Drug Type Shared antigen vaccine |
Synonyms DPX E7, HPV16-E711-19 |
Target |
Mechanism E7 inhibitors(Protein E7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anus Neoplasms | Phase 2 | US | 30 Mar 2017 | |
Head and Neck Neoplasms | Phase 2 | US | 30 Mar 2017 | |
Uterine Cervical Cancer | Phase 2 | US | 30 Mar 2017 | |
Solid tumor | Preclinical | US | - | - |
Phase 1/2 | 11 | (DPX-E7 + Cyclophosphamide [Phase Ib Cohort]) | epeudctmhj(ibpbasrmjc) = xepvrnftzj dpvcveirit (jkerkpoplj, ecthaoeapy - tgltwebpnq) View more | - | 11 Jan 2024 | ||
(DPX-E7 + Cyclophosphamide [Phase II Cohort 1]) | xgisafjkou(rwihnwkdtz) = excvhirqux roxvgvktlb (nmsknsdfft, intwseqsqa - okfvsuwung) View more |